• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·LBRX.US
Share

LB Pharmaceuticals Stocks

¤ 0Last Updated 11.09.2025

Issuer Rating

Performance

Risk

Recommendation

Sell

¤ 0
Key Takeaways

Risk factor

Profitability factor

Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

11.09.2025 15:00

Shares of schizophrenia drugmaker LB Pharmaceuticals debut on Nasdaq

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

04.08.2026 16:30

An analyst does not recommend Birkenstock stock. The brand could lose its premium status

04.08.2026 16:00

"We need to take a hard look at ourselves": BP has doubled its profits and is selling its "green" business in the U.S.

04.08.2026 15:45

Morning in New York: S&P 500 on the Verge of New Records

04.08.2026 15:15

A ship was attacked in the Strait of Hormuz. Trump gave Iran a "last chance" to reach a deal

04.08.2026 14:42

"The Numbers Don't Matter": What Analysts Will Be Looking for in SpaceX's First Post-IPO Report

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026